US Edition7 Articles
7 Articles
Supply problems are related to ‘an increase in sales of insulin cartridges, combined with a limited laboratory production capacity, which does not temporarily meet demand', according to ANSM.
According to the laboratory, tensions are expected until the end of 2025 for its injectable solutions used to treat diabetes in adults, adolescents and children.
Two insulin cartridges from the Danish Novo Nordisk laboratory, used by thousands of diabetic patients in France, are threatened with shortages in Europe, the French health authorities said this Tuesday.
French health authorities reported Tuesday that there are supply shortages in Europe for two pre-filled insulin cartridges from the Danish laboratory Novo Nordisk, used by several thousand diabetic patients in France.
The Danish laboratory has indicated that tensions in the supply of pre-filled insulin cartridges to people with diabetes are expected throughout Europe until the end of 2025.
The tensions concern the Fiasp PumpCart and NovoRapid PumpCart cartridges at the dosage of 100 units/mL, which are "specifically compatible with the YpsoPump insulin pump of the manufacturer Ypsomed", explains the French drug safety agency (ANSM) in a press release.
Coverage Details
Bias Distribution
- 50% of the sources are Center, 50% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
